

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.42060972 |
| 2 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.15324203 |
| 3 | * protein targeting to ER (GO:0045047) | 6.03165241 |
| 4 | * cotranslational protein targeting to membrane (GO:0006613) | 6.00146178 |
| 5 | viral transcription (GO:0019083) | 5.72954858 |
| 6 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.71778219 |
| 7 | * protein localization to endoplasmic reticulum (GO:0070972) | 5.70777484 |
| 8 | signal peptide processing (GO:0006465) | 5.58610383 |
| 9 | DNA deamination (GO:0045006) | 5.52597384 |
| 10 | translational termination (GO:0006415) | 5.51673635 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 5.34475301 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 5.34475301 |
| 13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.30481501 |
| 14 | ribosomal small subunit biogenesis (GO:0042274) | 5.19743830 |
| 15 | chaperone-mediated protein transport (GO:0072321) | 5.11455503 |
| 16 | respiratory electron transport chain (GO:0022904) | 5.06284568 |
| 17 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.98941067 |
| 18 | electron transport chain (GO:0022900) | 4.95251040 |
| 19 | translational elongation (GO:0006414) | 4.79676022 |
| 20 | protein complex biogenesis (GO:0070271) | 4.47487872 |
| 21 | viral life cycle (GO:0019058) | 4.41643623 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.41514799 |
| 23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.24384141 |
| 24 | protein neddylation (GO:0045116) | 4.24033207 |
| 25 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.17598363 |
| 26 | cellular protein complex disassembly (GO:0043624) | 4.16968215 |
| 27 | translational initiation (GO:0006413) | 4.16520227 |
| 28 | protein retention in ER lumen (GO:0006621) | 4.10337144 |
| 29 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.08715781 |
| 30 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.08715781 |
| 31 | NADH dehydrogenase complex assembly (GO:0010257) | 4.08715781 |
| 32 | * translation (GO:0006412) | 4.07810184 |
| 33 | * protein targeting to membrane (GO:0006612) | 3.94510699 |
| 34 | protein targeting to mitochondrion (GO:0006626) | 3.88992284 |
| 35 | GDP-mannose metabolic process (GO:0019673) | 3.85348686 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.83393901 |
| 37 | maturation of SSU-rRNA (GO:0030490) | 3.76540591 |
| 38 | protein maturation by protein folding (GO:0022417) | 3.74289728 |
| 39 | protein complex disassembly (GO:0043241) | 3.64951277 |
| 40 | establishment of protein localization to mitochondrion (GO:0072655) | 3.63097887 |
| 41 | cullin deneddylation (GO:0010388) | 3.62316185 |
| 42 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.60493243 |
| 43 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.58613133 |
| 44 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.58613133 |
| 45 | ribosomal large subunit biogenesis (GO:0042273) | 3.57724676 |
| 46 | protein localization to mitochondrion (GO:0070585) | 3.52767517 |
| 47 | protein deneddylation (GO:0000338) | 3.52058486 |
| 48 | positive regulation of ligase activity (GO:0051351) | 3.48032656 |
| 49 | macromolecular complex disassembly (GO:0032984) | 3.46720043 |
| 50 | oxidative phosphorylation (GO:0006119) | 3.30356464 |
| 51 | rRNA modification (GO:0000154) | 3.29394494 |
| 52 | hydrogen ion transmembrane transport (GO:1902600) | 3.27949953 |
| 53 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.25705741 |
| 54 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.18940522 |
| 55 | formation of translation preinitiation complex (GO:0001731) | 3.18229371 |
| 56 | regulation of cellular amine metabolic process (GO:0033238) | 3.18228645 |
| 57 | proteasome assembly (GO:0043248) | 3.17490812 |
| 58 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.16368213 |
| 59 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.14888218 |
| 60 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.14439325 |
| 61 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.12260638 |
| 62 | sequestering of metal ion (GO:0051238) | 3.12180630 |
| 63 | ATP biosynthetic process (GO:0006754) | 3.11816802 |
| 64 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.11755348 |
| 65 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.11398751 |
| 66 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.10145556 |
| 67 | positive regulation of cell cycle arrest (GO:0071158) | 3.06680587 |
| 68 | mitochondrial transport (GO:0006839) | 3.05410399 |
| 69 | GTP biosynthetic process (GO:0006183) | 3.04853278 |
| 70 | regulation of ligase activity (GO:0051340) | 3.03435497 |
| 71 | mRNA catabolic process (GO:0006402) | 3.02661064 |
| 72 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.01387797 |
| 73 | proton transport (GO:0015992) | 2.97994925 |
| 74 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.97667477 |
| 75 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.91328140 |
| 76 | hydrogen transport (GO:0006818) | 2.90732241 |
| 77 | COPII vesicle coating (GO:0048208) | 2.89400715 |
| 78 | deoxyribonucleotide catabolic process (GO:0009264) | 2.88174437 |
| 79 | negative regulation of protein ubiquitination (GO:0031397) | 2.86725698 |
| 80 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.86686399 |
| 81 | mannosylation (GO:0097502) | 2.83871230 |
| 82 | RNA catabolic process (GO:0006401) | 2.83501849 |
| 83 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.82525747 |
| 84 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.82525747 |
| 85 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.82007408 |
| 86 | deoxyribose phosphate catabolic process (GO:0046386) | 2.81963001 |
| 87 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.81497561 |
| 88 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.80256669 |
| 89 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.78960793 |
| 90 | rRNA metabolic process (GO:0016072) | 2.76535740 |
| 91 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.76289384 |
| 92 | DNA strand elongation (GO:0022616) | 2.75204524 |
| 93 | telomere maintenance via recombination (GO:0000722) | 2.73520184 |
| 94 | exocrine pancreas development (GO:0031017) | 2.72747741 |
| 95 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.71936924 |
| 96 | * establishment of protein localization to membrane (GO:0090150) | 2.69880564 |
| 97 | peptidyl-histidine modification (GO:0018202) | 2.68317207 |
| 98 | proline biosynthetic process (GO:0006561) | 2.65292860 |
| 99 | endocrine pancreas development (GO:0031018) | 2.64624265 |
| 100 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.62627574 |
| 101 | respiratory chain complex IV assembly (GO:0008535) | 2.61916013 |
| 102 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.61895138 |
| 103 | ATP synthesis coupled proton transport (GO:0015986) | 2.61895138 |
| 104 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.61490368 |
| 105 | * protein targeting (GO:0006605) | 2.60767565 |
| 106 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.58541079 |
| 107 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.58500966 |
| 108 | cellular component biogenesis (GO:0044085) | 2.58185277 |
| 109 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.57535818 |
| 110 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.57334950 |
| 111 | termination of RNA polymerase III transcription (GO:0006386) | 2.57334950 |
| 112 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.57138269 |
| 113 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.57138269 |
| 114 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.55675287 |
| 115 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.55675287 |
| 116 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.55675287 |
| 117 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.55300384 |
| 118 | regulation of mitochondrial translation (GO:0070129) | 2.53599626 |
| 119 | negative regulation of ligase activity (GO:0051352) | 2.52621288 |
| 120 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.52621288 |
| 121 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.50012712 |
| 122 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.49502223 |
| 123 | rRNA processing (GO:0006364) | 2.49195977 |
| 124 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.48778182 |
| 125 | pseudouridine synthesis (GO:0001522) | 2.47915847 |
| 126 | response to interferon-beta (GO:0035456) | 2.46779408 |
| 127 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.46276704 |
| 128 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45740655 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.45740655 |
| 130 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.45711002 |
| 131 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.45632092 |
| 132 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.45632092 |
| 133 | * establishment of protein localization to organelle (GO:0072594) | 2.44816528 |
| 134 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.43793656 |
| 135 | cytochrome complex assembly (GO:0017004) | 2.43477875 |
| 136 | peptidyl-asparagine modification (GO:0018196) | 2.43464326 |
| 137 | spliceosomal snRNP assembly (GO:0000387) | 2.43078852 |
| 138 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.42235692 |
| 139 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.41238971 |
| 140 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.39509955 |
| 141 | reactive oxygen species biosynthetic process (GO:1903409) | 2.38761399 |
| 142 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.37525035 |
| 143 | metallo-sulfur cluster assembly (GO:0031163) | 2.37242432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.92100446 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.80651600 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.72933822 |
| 4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.62777006 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.61866101 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.52203290 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.30743201 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.24754416 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.15825030 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.08685448 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.86578179 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.69688430 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.67840516 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.67295655 |
| 15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66431398 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.59030388 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40528565 |
| 18 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.34693696 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.34519524 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.28850594 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.27659466 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.22774397 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18496390 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.18147205 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.15229226 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.14807504 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.14749307 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11463834 |
| 29 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.09804756 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.03588141 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00538826 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97198825 |
| 33 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94441697 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.93717779 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91833616 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90621795 |
| 37 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.90277981 |
| 38 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.89746350 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.85296739 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.85223264 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79422969 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.77616730 |
| 43 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.77081227 |
| 44 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75944464 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.73877440 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70077266 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.69264650 |
| 48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58234542 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.56479343 |
| 50 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.56352947 |
| 51 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54785973 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52702944 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42634768 |
| 54 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.42226740 |
| 55 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38218246 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32213925 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.31825119 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31473018 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28613167 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27139314 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26900979 |
| 62 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24075452 |
| 63 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.24003592 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21921586 |
| 65 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.20399771 |
| 66 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20089844 |
| 67 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19235154 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19207728 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17653769 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17152491 |
| 71 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15741611 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15686051 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15359696 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15118630 |
| 75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14936222 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14166697 |
| 77 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.12780662 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09588898 |
| 79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09534230 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 1.09144327 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08776005 |
| 82 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08658742 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07520704 |
| 84 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05855657 |
| 85 | * DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04526864 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04334776 |
| 87 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04096579 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02269629 |
| 89 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02077465 |
| 90 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99919459 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99819145 |
| 92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.96544295 |
| 93 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91996129 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91592070 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91543562 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90100923 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89873492 |
| 98 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.89267528 |
| 99 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.88642848 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86749246 |
| 101 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.86479750 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86319150 |
| 103 | MYB_26560356_Chip-Seq_TH2_Human | 0.86287691 |
| 104 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85778108 |
| 105 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84156851 |
| 106 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84064295 |
| 107 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83558176 |
| 108 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82417468 |
| 109 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.82264486 |
| 110 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82180354 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78955525 |
| 112 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75458009 |
| 113 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.74792111 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.72687433 |
| 115 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.72143649 |
| 116 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.68095790 |
| 117 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67398851 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67248358 |
| 119 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.67216217 |
| 120 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.67216217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.59359359 |
| 2 | MP0009379_abnormal_foot_pigmentation | 2.58548547 |
| 3 | MP0005220_abnormal_exocrine_pancreas | 2.57287292 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.48994119 |
| 5 | MP0002693_abnormal_pancreas_physiology | 2.35461196 |
| 6 | MP0003718_maternal_effect | 2.34662710 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 2.28148429 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.17819642 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.11705466 |
| 10 | MP0003436_decreased_susceptibility_to | 2.07521445 |
| 11 | MP0003186_abnormal_redox_activity | 2.06423719 |
| 12 | MP0009785_altered_susceptibility_to | 2.05088499 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.04507296 |
| 14 | MP0001944_abnormal_pancreas_morphology | 2.00355766 |
| 15 | MP0006072_abnormal_retinal_apoptosis | 1.94827426 |
| 16 | MP0005671_abnormal_response_to | 1.91377142 |
| 17 | MP0003724_increased_susceptibility_to | 1.90931064 |
| 18 | MP0005084_abnormal_gallbladder_morpholo | 1.89269125 |
| 19 | MP0000490_abnormal_crypts_of | 1.82661252 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 1.82533262 |
| 21 | MP0006054_spinal_hemorrhage | 1.78678380 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.76917512 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.76395853 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 1.74324789 |
| 25 | MP0000685_abnormal_immune_system | 1.73795795 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.69029069 |
| 27 | MP0005025_abnormal_response_to | 1.66687945 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.66431642 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62280154 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.61946279 |
| 31 | MP0003283_abnormal_digestive_organ | 1.60781476 |
| 32 | MP0003195_calcinosis | 1.60319141 |
| 33 | MP0002254_reproductive_system_inflammat | 1.58036860 |
| 34 | MP0009697_abnormal_copulation | 1.57320781 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.56262756 |
| 36 | MP0001529_abnormal_vocalization | 1.56083125 |
| 37 | MP0006082_CNS_inflammation | 1.55200611 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.54517211 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.53887590 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.52932563 |
| 41 | MP0002163_abnormal_gland_morphology | 1.49124273 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.48388525 |
| 43 | MP0003077_abnormal_cell_cycle | 1.47138639 |
| 44 | MP0008058_abnormal_DNA_repair | 1.46043057 |
| 45 | MP0000858_altered_metastatic_potential | 1.45448296 |
| 46 | MP0002419_abnormal_innate_immunity | 1.40906603 |
| 47 | MP0003011_delayed_dark_adaptation | 1.40568461 |
| 48 | MP0005408_hypopigmentation | 1.40260801 |
| 49 | MP0002723_abnormal_immune_serum | 1.39924353 |
| 50 | MP0000613_abnormal_salivary_gland | 1.38940553 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.38212277 |
| 52 | MP0005332_abnormal_amino_acid | 1.37651548 |
| 53 | MP0001819_abnormal_immune_cell | 1.37172044 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.36526544 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.35664480 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.34996104 |
| 57 | MP0008007_abnormal_cellular_replicative | 1.34981017 |
| 58 | MP0008789_abnormal_olfactory_epithelium | 1.34789072 |
| 59 | MP0002405_respiratory_system_inflammati | 1.34643054 |
| 60 | MP0010094_abnormal_chromosome_stability | 1.29898322 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.29496525 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.29215736 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.28581331 |
| 64 | MP0001790_abnormal_immune_system | 1.28529531 |
| 65 | MP0005387_immune_system_phenotype | 1.28529531 |
| 66 | MP0003866_abnormal_defecation | 1.27369916 |
| 67 | MP0001800_abnormal_humoral_immune | 1.27126933 |
| 68 | MP0004043_abnormal_pH_regulation | 1.26640195 |
| 69 | MP0008932_abnormal_embryonic_tissue | 1.26279046 |
| 70 | MP0001919_abnormal_reproductive_system | 1.23731997 |
| 71 | MP0009764_decreased_sensitivity_to | 1.21911080 |
| 72 | MP0002638_abnormal_pupillary_reflex | 1.21040412 |
| 73 | MP0002398_abnormal_bone_marrow | 1.19599206 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.19551912 |
| 75 | MP0008995_early_reproductive_senescence | 1.19107701 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.18624283 |
| 77 | MP0002132_abnormal_respiratory_system | 1.17278362 |
| 78 | MP0001905_abnormal_dopamine_level | 1.16180038 |
| 79 | MP0005083_abnormal_biliary_tract | 1.16068032 |
| 80 | MP0002006_tumorigenesis | 1.15516294 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 1.15478430 |
| 82 | MP0000716_abnormal_immune_system | 1.14658322 |
| 83 | MP0002102_abnormal_ear_morphology | 1.14355668 |
| 84 | MP0001666_abnormal_nutrient_absorption | 1.14046472 |
| 85 | MP0001881_abnormal_mammary_gland | 1.14042760 |
| 86 | MP0005389_reproductive_system_phenotype | 1.12748856 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 1.12368417 |
| 88 | MP0008469_abnormal_protein_level | 1.11961070 |
| 89 | MP0001873_stomach_inflammation | 1.10970033 |
| 90 | MP0001853_heart_inflammation | 1.10508916 |
| 91 | MP0002277_abnormal_respiratory_mucosa | 1.09411912 |
| 92 | MP0002429_abnormal_blood_cell | 1.09042948 |
| 93 | MP0002722_abnormal_immune_system | 1.06454591 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 1.05937450 |
| 95 | MP0001533_abnormal_skeleton_physiology | 1.05791667 |
| 96 | MP0001542_abnormal_bone_strength | 1.05566258 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 1.04514817 |
| 98 | MP0009840_abnormal_foam_cell | 1.04462407 |
| 99 | MP0002938_white_spotting | 1.04256503 |
| 100 | MP0006292_abnormal_olfactory_placode | 1.03422692 |
| 101 | MP0000689_abnormal_spleen_morphology | 1.02878787 |
| 102 | MP0005058_abnormal_lysosome_morphology | 1.02596190 |
| 103 | MP0002019_abnormal_tumor_incidence | 1.01547858 |
| 104 | MP0008872_abnormal_physiological_respon | 1.01277681 |
| 105 | MP0005310_abnormal_salivary_gland | 1.01230453 |
| 106 | MP0005360_urolithiasis | 1.01077755 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.99673450 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.99588590 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.99152697 |
| 110 | MP0003111_abnormal_nucleus_morphology | 0.98755974 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.97294656 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.97238118 |
| 113 | MP0004147_increased_porphyrin_level | 0.97091549 |
| 114 | MP0002933_joint_inflammation | 0.94748174 |
| 115 | MP0004142_abnormal_muscle_tone | 0.92974783 |
| 116 | MP0002090_abnormal_vision | 0.92299378 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.92171933 |
| 118 | MP0000372_irregular_coat_pigmentation | 0.90903710 |
| 119 | MP0001764_abnormal_homeostasis | 0.90449338 |
| 120 | MP0001727_abnormal_embryo_implantation | 0.90416700 |
| 121 | MP0002928_abnormal_bile_duct | 0.89178256 |
| 122 | MP0005365_abnormal_bile_salt | 0.89142589 |
| 123 | MP0005395_other_phenotype | 0.87802239 |
| 124 | MP0003786_premature_aging | 0.87107363 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.86985433 |
| 126 | MP0000358_abnormal_cell_content/ | 0.86497357 |
| 127 | MP0000313_abnormal_cell_death | 0.85585149 |
| 128 | MP0005410_abnormal_fertilization | 0.85363545 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.84572788 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.83967124 |
| 131 | MP0008057_abnormal_DNA_replication | 0.83612706 |
| 132 | MP0005253_abnormal_eye_physiology | 0.83523848 |
| 133 | MP0008873_increased_physiological_sensi | 0.81407001 |
| 134 | MP0003795_abnormal_bone_structure | 0.78451426 |
| 135 | MP0002095_abnormal_skin_pigmentation | 0.78171927 |
| 136 | MP0003123_paternal_imprinting | 0.77431690 |
| 137 | MP0002078_abnormal_glucose_homeostasis | 0.75512468 |
| 138 | MP0009763_increased_sensitivity_to | 0.75303758 |
| 139 | MP0001756_abnormal_urination | 0.74973618 |
| 140 | MP0004019_abnormal_vitamin_homeostasis | 0.73753143 |
| 141 | MP0001119_abnormal_female_reproductive | 0.73343962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.04314526 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.71993502 |
| 3 | Reticulocytopenia (HP:0001896) | 4.48336178 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 4.36212460 |
| 5 | Cerebral edema (HP:0002181) | 4.33351950 |
| 6 | Aplastic anemia (HP:0001915) | 3.99730458 |
| 7 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.79432455 |
| 8 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.79432455 |
| 9 | Abnormal protein glycosylation (HP:0012346) | 3.79432455 |
| 10 | Abnormal glycosylation (HP:0012345) | 3.79432455 |
| 11 | Reduced antithrombin III activity (HP:0001976) | 3.65186613 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.40807301 |
| 13 | Thrombocytosis (HP:0001894) | 3.32572712 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.30173867 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.30173867 |
| 16 | Pallor (HP:0000980) | 3.20638652 |
| 17 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.20546000 |
| 18 | Macrocytic anemia (HP:0001972) | 3.19054653 |
| 19 | Hepatic necrosis (HP:0002605) | 3.12407535 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.09965425 |
| 21 | Hypoglycemic seizures (HP:0002173) | 3.08207049 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.02067917 |
| 23 | Exertional dyspnea (HP:0002875) | 2.90647209 |
| 24 | Mitochondrial inheritance (HP:0001427) | 2.90559704 |
| 25 | Methylmalonic aciduria (HP:0012120) | 2.86643774 |
| 26 | Symptomatic seizures (HP:0011145) | 2.84510814 |
| 27 | Leukodystrophy (HP:0002415) | 2.78474461 |
| 28 | Lethargy (HP:0001254) | 2.77483523 |
| 29 | Poor head control (HP:0002421) | 2.75561713 |
| 30 | Increased hepatocellular lipid droplets (HP:0006565) | 2.73685189 |
| 31 | Optic disc pallor (HP:0000543) | 2.72611304 |
| 32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.72446376 |
| 33 | Acute necrotizing encephalopathy (HP:0006965) | 2.71233727 |
| 34 | Hepatocellular necrosis (HP:0001404) | 2.70806553 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.69098730 |
| 36 | 11 pairs of ribs (HP:0000878) | 2.67929540 |
| 37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.66956872 |
| 38 | Dicarboxylic aciduria (HP:0003215) | 2.64477634 |
| 39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64477634 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.62288019 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55313158 |
| 42 | Renal Fanconi syndrome (HP:0001994) | 2.48690125 |
| 43 | Late onset (HP:0003584) | 2.48342203 |
| 44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.46543546 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42147093 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.41651255 |
| 47 | CNS demyelination (HP:0007305) | 2.41204180 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.40739528 |
| 49 | Increased CSF lactate (HP:0002490) | 2.37960492 |
| 50 | Microretrognathia (HP:0000308) | 2.30642404 |
| 51 | Increased serum pyruvate (HP:0003542) | 2.27942557 |
| 52 | IgM deficiency (HP:0002850) | 2.27513943 |
| 53 | Acute encephalopathy (HP:0006846) | 2.27404887 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 2.26796688 |
| 55 | Congenital, generalized hypertrichosis (HP:0004540) | 2.25778315 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.21421366 |
| 57 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21418492 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.20698888 |
| 59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20496660 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.20377561 |
| 61 | Petechiae (HP:0000967) | 2.19378150 |
| 62 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.19237156 |
| 63 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.18583591 |
| 64 | Abnormal hemoglobin (HP:0011902) | 2.15307928 |
| 65 | Abnormality of the anterior horn cell (HP:0006802) | 2.14695539 |
| 66 | Degeneration of anterior horn cells (HP:0002398) | 2.14695539 |
| 67 | Nausea (HP:0002018) | 2.14068128 |
| 68 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.12220003 |
| 69 | Glycosuria (HP:0003076) | 2.06197504 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.06197504 |
| 71 | Emotional lability (HP:0000712) | 2.05598476 |
| 72 | X-linked dominant inheritance (HP:0001423) | 2.04281814 |
| 73 | Hyperphosphaturia (HP:0003109) | 2.02013135 |
| 74 | Oral leukoplakia (HP:0002745) | 2.00380579 |
| 75 | Eczematoid dermatitis (HP:0000976) | 1.99516117 |
| 76 | Thoracolumbar scoliosis (HP:0002944) | 1.99409600 |
| 77 | Cleft eyelid (HP:0000625) | 1.99181607 |
| 78 | Myositis (HP:0100614) | 1.97203156 |
| 79 | Dysostosis multiplex (HP:0000943) | 1.95580177 |
| 80 | Abnormality of glycolysis (HP:0004366) | 1.95130621 |
| 81 | Progressive macrocephaly (HP:0004481) | 1.93306315 |
| 82 | Beaking of vertebral bodies (HP:0004568) | 1.93209606 |
| 83 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.93165102 |
| 84 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.93165102 |
| 85 | Testicular atrophy (HP:0000029) | 1.89935509 |
| 86 | Progressive neurologic deterioration (HP:0002344) | 1.89880856 |
| 87 | Increased serum lactate (HP:0002151) | 1.89741834 |
| 88 | IgG deficiency (HP:0004315) | 1.89724642 |
| 89 | Abnormality of serum amino acid levels (HP:0003112) | 1.84244332 |
| 90 | Mucopolysacchariduria (HP:0008155) | 1.83189062 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83189062 |
| 92 | Abnormality of T cells (HP:0002843) | 1.81935579 |
| 93 | 3-Methylglutaconic aciduria (HP:0003535) | 1.81457749 |
| 94 | Vomiting (HP:0002013) | 1.81086811 |
| 95 | Flat capital femoral epiphysis (HP:0003370) | 1.80041971 |
| 96 | Exercise intolerance (HP:0003546) | 1.78361994 |
| 97 | Rough bone trabeculation (HP:0100670) | 1.77235026 |
| 98 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77090837 |
| 99 | Sparse eyelashes (HP:0000653) | 1.76190922 |
| 100 | Pancytopenia (HP:0001876) | 1.76132150 |
| 101 | Hyperglycinemia (HP:0002154) | 1.75123286 |
| 102 | Abnormal pancreas size (HP:0012094) | 1.75006870 |
| 103 | Multiple enchondromatosis (HP:0005701) | 1.74674166 |
| 104 | Abnormality of renal resorption (HP:0011038) | 1.74281591 |
| 105 | Amniotic constriction ring (HP:0009775) | 1.74209837 |
| 106 | Abnormality of placental membranes (HP:0011409) | 1.74209837 |
| 107 | Hypothermia (HP:0002045) | 1.73900118 |
| 108 | Blindness (HP:0000618) | 1.71583832 |
| 109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71305476 |
| 110 | Abnormality of alanine metabolism (HP:0010916) | 1.71305476 |
| 111 | Hyperalaninemia (HP:0003348) | 1.71305476 |
| 112 | Lactic acidosis (HP:0003128) | 1.71068870 |
| 113 | Neutropenia (HP:0001875) | 1.70706415 |
| 114 | Premature graying of hair (HP:0002216) | 1.70525250 |
| 115 | Hyperparathyroidism (HP:0000843) | 1.69655383 |
| 116 | Abnormality of vitamin B metabolism (HP:0004340) | 1.68672659 |
| 117 | Depressed nasal ridge (HP:0000457) | 1.67194570 |
| 118 | Trismus (HP:0000211) | 1.66451115 |
| 119 | Progressive microcephaly (HP:0000253) | 1.66313510 |
| 120 | Respiratory difficulties (HP:0002880) | 1.65479837 |
| 121 | Stomatitis (HP:0010280) | 1.64711144 |
| 122 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.64456747 |
| 123 | Palpitations (HP:0001962) | 1.61163672 |
| 124 | Progressive muscle weakness (HP:0003323) | 1.60841155 |
| 125 | Meningitis (HP:0001287) | 1.60586268 |
| 126 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.60487919 |
| 127 | Abnormality of macrophages (HP:0004311) | 1.60307736 |
| 128 | Birth length less than 3rd percentile (HP:0003561) | 1.59496923 |
| 129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.59149486 |
| 130 | Microvesicular hepatic steatosis (HP:0001414) | 1.58590183 |
| 131 | Gliosis (HP:0002171) | 1.57702724 |
| 132 | Optic nerve coloboma (HP:0000588) | 1.57397882 |
| 133 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.56967965 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.56399304 |
| 135 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.56399304 |
| 136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.56399304 |
| 137 | Respiratory failure (HP:0002878) | 1.56112603 |
| 138 | Hypoplasia of the uterus (HP:0000013) | 1.54658280 |
| 139 | Opisthotonus (HP:0002179) | 1.54586371 |
| 140 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.53699436 |
| 141 | Abnormality of midbrain morphology (HP:0002418) | 1.53281666 |
| 142 | Molar tooth sign on MRI (HP:0002419) | 1.53281666 |
| 143 | Parakeratosis (HP:0001036) | 1.53245209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.55199255 |
| 2 | NME2 | 4.24807570 |
| 3 | STK16 | 3.21575010 |
| 4 | PASK | 3.18222493 |
| 5 | ERN1 | 2.89595389 |
| 6 | MAP3K12 | 2.81281196 |
| 7 | EIF2AK3 | 2.78994478 |
| 8 | PIM2 | 2.69203471 |
| 9 | TAOK3 | 2.67093371 |
| 10 | MAPK15 | 2.53278372 |
| 11 | IRAK3 | 2.19466404 |
| 12 | MAP4K2 | 2.19324630 |
| 13 | BCKDK | 2.10765509 |
| 14 | IRAK4 | 2.03167011 |
| 15 | BUB1 | 2.03101595 |
| 16 | TESK2 | 2.02240245 |
| 17 | VRK1 | 2.00221200 |
| 18 | FLT3 | 1.96993761 |
| 19 | NUAK1 | 1.87574633 |
| 20 | NEK1 | 1.84691825 |
| 21 | EIF2AK1 | 1.68303474 |
| 22 | WEE1 | 1.64829488 |
| 23 | ACVR1B | 1.64053952 |
| 24 | DYRK3 | 1.64048275 |
| 25 | TESK1 | 1.62923022 |
| 26 | TEC | 1.55328059 |
| 27 | TRIM28 | 1.54401068 |
| 28 | TLK1 | 1.53947336 |
| 29 | BRSK2 | 1.44013290 |
| 30 | SCYL2 | 1.41009831 |
| 31 | RPS6KA4 | 1.38288303 |
| 32 | PIK3CG | 1.36584503 |
| 33 | INSRR | 1.35228483 |
| 34 | BTK | 1.34272446 |
| 35 | KDR | 1.31106617 |
| 36 | BRAF | 1.30731460 |
| 37 | PDK2 | 1.28954452 |
| 38 | MYLK | 1.27027036 |
| 39 | MAP4K1 | 1.24651670 |
| 40 | BLK | 1.24204134 |
| 41 | MST4 | 1.23837945 |
| 42 | CSNK1G3 | 1.22291683 |
| 43 | SRPK1 | 1.20160969 |
| 44 | ZAP70 | 1.20150189 |
| 45 | ARAF | 1.19959845 |
| 46 | HIPK2 | 1.19086011 |
| 47 | RPS6KB2 | 1.14504442 |
| 48 | TYK2 | 1.13290597 |
| 49 | JAK3 | 1.11746280 |
| 50 | CDK19 | 1.08874913 |
| 51 | TBK1 | 1.08390744 |
| 52 | PLK4 | 1.06326252 |
| 53 | PBK | 1.06005612 |
| 54 | PLK3 | 1.04577389 |
| 55 | MAPKAPK3 | 1.03487099 |
| 56 | MAP2K2 | 1.02321645 |
| 57 | MAP3K14 | 1.00948318 |
| 58 | NME1 | 0.99098589 |
| 59 | CSNK1G1 | 0.98267936 |
| 60 | IKBKB | 0.95016791 |
| 61 | WNK3 | 0.94401577 |
| 62 | DAPK3 | 0.94316503 |
| 63 | NLK | 0.94307404 |
| 64 | MAP3K11 | 0.94249418 |
| 65 | GRK1 | 0.91791753 |
| 66 | CDK8 | 0.90835578 |
| 67 | CSNK1G2 | 0.87815587 |
| 68 | ABL2 | 0.86304825 |
| 69 | LIMK1 | 0.85314739 |
| 70 | AURKB | 0.85002461 |
| 71 | PIM1 | 0.84454146 |
| 72 | DAPK1 | 0.84030474 |
| 73 | LRRK2 | 0.80964142 |
| 74 | CDK7 | 0.80263408 |
| 75 | FRK | 0.75937832 |
| 76 | GRK7 | 0.75457218 |
| 77 | TGFBR1 | 0.75276997 |
| 78 | CSNK1A1L | 0.74227844 |
| 79 | BMPR1B | 0.73878376 |
| 80 | IRAK1 | 0.73044281 |
| 81 | EIF2AK2 | 0.71739870 |
| 82 | SYK | 0.71696488 |
| 83 | LYN | 0.70965595 |
| 84 | IKBKE | 0.70238354 |
| 85 | KIT | 0.68808816 |
| 86 | TXK | 0.68680669 |
| 87 | CDC7 | 0.66305486 |
| 88 | DYRK1B | 0.64036193 |
| 89 | TSSK6 | 0.63215380 |
| 90 | TTK | 0.60186088 |
| 91 | AURKA | 0.58728895 |
| 92 | PAK4 | 0.58317022 |
| 93 | PRKCI | 0.58043319 |
| 94 | PLK1 | 0.58009970 |
| 95 | ATR | 0.55778476 |
| 96 | CSNK2A1 | 0.55624138 |
| 97 | ERBB3 | 0.55605945 |
| 98 | MAP3K3 | 0.55494564 |
| 99 | MAP3K8 | 0.55320823 |
| 100 | DYRK2 | 0.53081049 |
| 101 | EPHA2 | 0.52908965 |
| 102 | OXSR1 | 0.52537447 |
| 103 | RPS6KA5 | 0.51973706 |
| 104 | PRKG2 | 0.51867891 |
| 105 | ILK | 0.51351483 |
| 106 | CHUK | 0.50848837 |
| 107 | MATK | 0.50322157 |
| 108 | ZAK | 0.47901034 |
| 109 | CLK1 | 0.46454778 |
| 110 | CSNK2A2 | 0.46428190 |
| 111 | ADRBK2 | 0.45752334 |
| 112 | CSK | 0.45541215 |
| 113 | ITK | 0.44437537 |
| 114 | TAOK2 | 0.43585626 |
| 115 | TAF1 | 0.42036453 |
| 116 | MKNK1 | 0.41818612 |
| 117 | BRSK1 | 0.41516601 |
| 118 | NEK9 | 0.39567503 |
| 119 | PAK1 | 0.39381837 |
| 120 | MAPKAPK2 | 0.39069482 |
| 121 | NEK2 | 0.38657532 |
| 122 | BMPR2 | 0.37288527 |
| 123 | STK24 | 0.37195254 |
| 124 | YES1 | 0.36993405 |
| 125 | STK4 | 0.35155868 |
| 126 | CHEK2 | 0.34519459 |
| 127 | CSNK1A1 | 0.33425597 |
| 128 | BCR | 0.32531893 |
| 129 | MKNK2 | 0.32442880 |
| 130 | LCK | 0.32063958 |
| 131 | CSF1R | 0.31684680 |
| 132 | MAP2K7 | 0.29694254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Protein export_Homo sapiens_hsa03060 | 4.92637078 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.90391257 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.88808357 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.19417064 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.92819714 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.34375532 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.23685720 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.09618537 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.07245852 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04338558 |
| 11 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.95321491 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.88785416 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 1.86247338 |
| 14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.84151358 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81610338 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.77549408 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.74829778 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74118927 |
| 19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.65103401 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.60361475 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50968468 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.46136012 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40673953 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31042261 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28644283 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28579820 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.28274374 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24318736 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22786954 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18616761 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16167823 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.13416728 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12558148 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12023008 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12018959 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11295310 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.10708412 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.07005674 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03561046 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.02739270 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97189122 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.96362460 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96253902 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96030911 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95749397 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95573474 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95191698 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 0.95050206 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94969150 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94094128 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.93764771 |
| 52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93518317 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93474279 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92005701 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87689486 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.86924980 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85141261 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79489219 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79471087 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78751415 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.76495156 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74870471 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74187690 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73760773 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73503379 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70719804 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70638323 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70594560 |
| 69 | Lysosome_Homo sapiens_hsa04142 | 0.70395481 |
| 70 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70392145 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69725870 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69588980 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69051153 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69042275 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69035683 |
| 76 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67471678 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66822212 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65898127 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65249902 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64404848 |
| 81 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63503171 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62200009 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.61932519 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.60954877 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60734639 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60720334 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57962569 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57426107 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55315375 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55064268 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53287989 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50799455 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50727689 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50675119 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50380147 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49980033 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.48681640 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.47043844 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46143287 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45965092 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44704959 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43672538 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42460657 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42385447 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40610202 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.40073025 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37297747 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37231651 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36776563 |
| 110 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36644691 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36431053 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36055115 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34794643 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34087309 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33872494 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33371911 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33124347 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.32926988 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32634494 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32123002 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31118484 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29627315 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28215823 |
| 124 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28056784 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28041823 |
| 126 | Malaria_Homo sapiens_hsa05144 | 0.26991961 |
| 127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26784769 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26112596 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25835366 |
| 130 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25778321 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.25771088 |
| 132 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25119762 |
| 133 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.24364685 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.23198782 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23061325 |

